Article
Dihydropteroate synthase polymorphisms in Pneumocystis carinii.
The Journal of infectious diseases - 1 Feb 1997
Lane B R, Ast J C, Hossler P A, Mindell D P, Bartlett M S, Smith J W, Meshnick S R
Abstract excerpt
Sulfa drugs are widely used in the treatment and prophylaxis of Pneumocystis carinii pneumonia. The nucleotide sequences of the sulfa target enzyme, dihydropteroate synthase (DHPS), differed substantially in human-, rat-, and mouse-derived P. carinii. Sequence variation also existed in the DHPSs from human-derived isolates. Six nucleotide changes were found in 6 human isolates; each was nonsynonymous and resulted...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
